# Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-tolerability-of-fremanezumab-for-the-prevention-of-migraine-a-pooled/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephen D. Silberstein,Peter McAllister,Xiaoping Ning,Nicola Faulhaber,Nicole Lang,Paul Yeung,Jimmy Schiemann,Ernesto Aycardi,Joshua M. Cohen,Lindsay Janka,Ronghua Yang |
| Citations | 54 |
| DOI | 10.1111/head.13534 |
| Fields | Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2937977035 |
| PMID | 30977520 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Joshua M. Cohen](https://scholariq.org/researchers/joshua-m-cohen/)

## Paper journal

- [Headache The Journal of Head and Face Pain](https://scholariq.org/journals/headache-the-journal-of-head-and-face-pain/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Vestibular and auditory disorders](https://scholariq.org/topics/vestibular-and-auditory-disorders/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.